Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Ophthalmology. 2012 Dec 1;120(3):451–456. doi: 10.1016/j.ophtha.2012.09.007

Table 2.

Patient Demographics

Kaiser Hawaii Confirmed HZO Cases P-value1
Total 217, 0612 134
 Female 110,701 (51%) 71 (53%) 0.67
 Age Category (years)
  0–14 40,057 (18%) 2 (1%) <0.001
  15–24 28,047 (13%) 4 (3%) <0.001
  25–44 58,376 (27%) 18 (13%) <0.001
  45–64 63,914 (29%) 54 (40%) 0.008
  ≥65 26,667 (12%) 56 (42%) <0.001
 Race N=114,505 (53%)3 N=102 (76%)4 <0.001
  Alaskan/Native American 1,463 (1%) 1 (1%) 1.00
  Asian 46,024 (40%) 47 (46%) 0.23
  Black 1,758 (2%) 2 (2%) 0.67
  Pacific Islander 31,083 (27%) 17 (17%) 0.02
  White 30,603 (27%) 34 (33%) 0.15
  Other 3,574 (3%) 1 (1%) 0.38

HZO = herpes zoster ophthalmicus

1

Fisher’s exact test

2

General membership of Kaiser Permanente Hawaii on January 1, 2007

3

The race distribution for the subgroup of the population reporting race was used to calculate the person-time denominators for each race in all incidence calculations by racial subgroup.

4

The race distribution for the subgroup of incident cases reporting race was used to calculate an adjusted number of total incident cases for each race in all incidence calculations by racial subgroup.